Clinical Pharmacology of Serotonin Receptor Type 3 (5-HT3) Antagonists

Publisher： Bentham Science Publishers

E-ISSN： 1875-6158|1|2|171-199

ISSN： 1568-0150

Source： Current Medicinal Chemistry - Central Nervous System Agents, Vol.1, Iss.2, 2001-08, pp. : 171-199

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

5-HT3 receptor antagonists

By Higgins G.A.   Kilpatrick G.J.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 12, 1999-12 ,pp. : 2183-2188

Informa Healthcare

Access to resources Recommend Favorite

5-HT 3 receptor antagonists and anxiety; a preclinical and clinical review

By Olivier B.   van Wijngaarden I.   Soudijn W.  

European Neuropsychopharmacology, Vol. 10, Iss. 2, 2000-03 ,pp. : 77-95

Elsevier

Access to resources Recommend Favorite

Selective Serotonin 5-HT3 Receptor Antagonists for Postoperative Nausea and Vomiting: Are They All the Same?

By Tong J. Gan  

CNS Drugs, Vol. 19, Iss. 3, 2005-01 ,pp. : 225-238

Adis International

Access to resources Recommend Favorite

Advances in use of the 5-HT3 receptor antagonists

By Walton S.M.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 2, 2000-01 ,pp. : 207-223

Informa Healthcare

Access to resources Recommend Favorite

Are All 5-HT3 Receptor Antagonists the Same?

By McNulty Robert  

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 5, Iss. 1, 2007-01 ,pp. : 35-43

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite